Table 1.
Most significant diseases and function affected in AKT-CAT, AKT-CAT+DDC, and AKT-CAT+CCl4 tumors
| Tumor group | p-Value |
|---|---|
| Shared by all tumor groups | |
| AKT-CAT | |
| Cell Death and Survival | 6.68E-07-1.33E-02 |
| Cancer | 2.32E-06-1.34E-02 |
| AKT-CAT+DDC | |
| Cell Death and Survival | 5.2E-14-2.29E-03 |
| Cancer | 6.03E-11-2.46E-03 |
| AKT-CAT+CCl4 | |
| Cell Death and Survival | 1.82E-09-1.04E-02 |
| Cancer | 2.33E-06-1.05E-02 |
| Shared by AKT-CAT+DDC and AKT-CAT+CCl4 | |
| AKT-CAT+DDC | |
| Cellular Growth and Proliferation | 1.75E-13-2.23E-03 |
| AKT-CAT+CCl4 | |
| Cellular Growth and Proliferation | 5.12E-10-1.06E-02 |
| Unique in each tumor group | |
| AKT-CAT | |
| Cell Signaling | 6.7E-07-3.53E-03 |
| Tumor Morphology | 2.32E-06-1.33E-02 |
| Organismal Injury and Abnormalities | 1.28E-05-1.33E-02 |
| AKT-CAT+DDC | |
| Cardiovascular Disease | 2.01E-10-2.29E-03 |
| Development Disorder | 1.17E-09-4.97E-04 |
| AKT-CAT+CCl4 | |
| Cardiovascular System Development and Function | 6.19E-08-1.02E-02 |
| Organismal Development | 6.19E-08-1.02E-02 |